[MiR-196a-2 gene polymorphism and the antiviral therapy of chronic hepatitis C].

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

[MiR-196a-2 gene polymorphism and the antiviral therapy of chronic hepatitis C].

Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology - 1 Dec 2010

Hong Xiao-Lv, Cao Hong, Zhao Fang, Pan Xing-Fei, Zhang Ka, Xu Qi-Huan, Zhao Zhi-Xin, Li Gang

Abstract excerpt

OBJECTIVE: To investigate the relationship between the SNP rs11614913 on miR196a-2 gene and the treatment effects of Peg-IFN-a plus Ribavirin on chronic hepatitis C patients. METHODS: The total 139 patients of chronic hepatitis C infection who received the treatment of Peg-IFN-alpha-2a or Peg-IFN...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to MicroRNAs

Share to Polyethylene Glycols

Share to Recombinant Proteins

Share to Ribavirin

Source

Open in PubMed

Identifiers

PMID: 21604580

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21604580-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[MiR-196a-2 gene polymorphism and the antiviral therapy of chronic hepatitis C].PMID 21604580Read ↗

[Investigation of the Relationship Between TNF-α, IL-12A, IL-12B and IFN-γ Gene Polymorphisms and Chronic Hepatitis C].Semantic proximity Read ↗

MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B.Semantic proximity Read ↗

Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.Semantic proximity Read ↗

MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis.Semantic proximity Read ↗

Association between Genetic Polymorphisms in MicroRNAs 196a2 (rs11614913) and 34 b/c (rs4938723) and Risk of Hepatocellular Carcinoma in Egyptian Patients.Semantic proximity Read ↗

Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population.Semantic proximity Read ↗

[The drug resistance mutation detection and relevant factors analysis of HBV P region in chronic hepatitis B patients in Weifang City, Shandong Province].Semantic proximity Read ↗

A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.Semantic proximity Read ↗

Associations between three common MicroRNA polymorphisms and hepatocellular carcinoma risk in Chinese.Semantic proximity Read ↗

Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.Semantic proximity Read ↗

Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4.Semantic proximity Read ↗

Impact of TGF-β1 Gene Polymorphism (rs1800469) on Treatment Response to Pegylated Interferon/Ribavirin in Iranian Patients with Hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.